openPR Logo
Press release

Implantable Drug Delivery Market is expected to reach USD 36.12 billion by 2025 A report by top market competitors like Bayer, Boston Scientific, Medtronic, Merck&Co. Inc., Allergan Inc., Bausch and Lomb, Inc., ithetis, Nucletron,Genetech Inc and more

01-18-2019 03:20 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Implantable Drug Delivery Market is expected to reach USD 36.12

Implantable drug delivery devices are medical devices that allow site specific drug management. It also offers the minimization of the doses of drug for the reduction of potential side effects. The implantable devices are reaching more attention as compared to the conservative oral and parenteral dosage forms because of the site specific and sustained release therapeutic action, implantable devices that again minimizes the side-effects associated with the drug. The most prominent cause of blindness in people is implantable drug delivery between the ages of 20-64 in the United States. According to a study by National Eye Institute (NEI), almost 5.4 million people in the U.S. will suffer from Age related Macular Degeneration (AMD) by 2050. Due to this the number of surgeries increasing and will cause the implantable drug delivery devices market to grow.
The Global Implantable Drug Delivery Market is expected to reach USD 36.12 billion by 2025, from USD 19.36 billion in 2017 growing at a CAGR of 8.0% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Get Exclusive Free Sample Report at: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-implantable-drug-delivery-market

Benefits of this Report
• Current and future of global implantable drug delivery market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

Major Market Drivers and Restraints:
• Increasing Adaptation Towards Minimally Invasive Surgeries
• Increasing Prevalence Of Chronic Diseases
• Rising Emerging Economies
• Rising Number Of Product Recalls
• Stringent Government Regulations

Major Market Competitors/Players: Global Implantable Drug Delivery Market
Some of the major players operating in the global implantable drug delivery market are Bayer, Boston Scientific, Medtronic, Merck&Co. Inc., Allergan Inc., Bausch and Lomb, Inc., ithetis, Nucletron,Genetech Inc., Theragenics, Psivida, Kinamed Inc., K2M Inc., Mako Surgical Corp., Varian Medical System, Arrow International, Eckert Ziegler, Elekta, JVS, and Abbottamong among others.

Request Analyst Call for More Insight @ https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-implantable-drug-delivery-market

Competitive Analysis: Global Implantable Drug Delivery Market
The global implantable drug delivery market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of implantable drug delivery market for global, Europe, North America, Asia Pacific and South America.

Market Segmentation:
Global Implantable Drug Delivery Market By technology the global implantable drug delivery market is segmented into biodegradable implantable drug delivery device technology and non-biodegradable implantable drug delivery device technology.
• On the basis of application the global implantable drug delivery market is segmented into cardiovascular, birth control & contraception, ophthalmology, oncology and others.
• Based on geography, the market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, South Africa and, Brazil among others.
Key Developments in the Market:
• In March 2016, FDA approved V-Go, a wearable 24 hour subcutaneous insulin delivery device by Medtronic for diabetes management, which have helped diabetes treatment outcome.
• In April 2013, Bayer Healthcare launched a hormonal intrauterine device (IUD) called Skyla. The product is launched in Europe with the brand name Jaydess, and is used for the prevention of pregnancy for up to three years.
…And More GET DETAILED TOC AT: https://databridgemarketresearch.com/toc/?dbmr=global-implantable-drug-delivery-market

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients’ needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delves into the markets across Asia, North America, South America and Africa to name few. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Implantable Drug Delivery Market is expected to reach USD 36.12 billion by 2025 A report by top market competitors like Bayer, Boston Scientific, Medtronic, Merck&Co. Inc., Allergan Inc., Bausch and Lomb, Inc., ithetis, Nucletron,Genetech Inc and more here

News-ID: 1513313 • Views:

More Releases from Data Bridge Market Research

Hibiscus Flower Powder Market Size, Share, Trends, Growth, Strategies, Opportunities, Top Companies, Regional Analysis and Forecast
Hibiscus Flower Powder Market Size, Share, Trends, Growth, Strategies, Opportuni …
The trustworthy Hibiscus Flower Powder Market study details the key actions taken by the leading companies and brands, including innovations, product launches, mergers, joint ventures, acquisitions, and competitive analysis in the industry. This winning market paper can cover more ground than just market scenarios and main players' pricing comparisons. It's a comprehensive background study of the sector that also estimates the parental market. A top-notch Hibiscus Flower Powder Market research report
Caffeinated Beverage Market Business Opportunities, Future Industry Trends, Strategies, Revenue, Challenges, Top Players and Forecast
Caffeinated Beverage Market Business Opportunities, Future Industry Trends, Stra …
A crucial source of information, the Caffeinated Beverage Market Research Report provides approaching and current technological and financial aspects of the industry through 2030. For the benefit of readers and end users, all gathered market data is verified and confirmed by industry professionals. With the help of this reliable marketing report, analyzing the actions of major companies and their impact on sales, import, export, revenue, and CAGR numbers becomes simple. The
Oral Cancer Treatment Market Size, Share, Industry Growth, Global Trends, Business Opportunities, Upcoming Demand Status, Revenue and Forecast
Oral Cancer Treatment Market Size, Share, Industry Growth, Global Trends, Busine …
When it comes to developing long-term and lucrative business plans, valuable and applicable market insights are crucial. A business study on the Oral Cancer Treatment Market is very helpful when planning production, new product launches, pricing, inventories, acquisitions, and marketing tactics. Categorization by companies, region, type, and end-use industry is provided in this market analysis. This market research report holds the key to better decision-making, increased income generation, and profitable business
Milking Systems Market Size, Share, Trends, Growth Overview by Segments, Companies, Regions, Industry Overview & Forecast
Milking Systems Market Size, Share, Trends, Growth Overview by Segments, Compani …
An important Milking Systems Market research report is produced by taking into account every requirement that organizations need to meet in order to expand successfully. This market report forecasts the market size based on data on major retailer sales, industry growth by upstream and downstream factors, industry advancement, major players, market segments, and application. When creating the reliable Milking Systems Market study, the goals of the marketing research are taken into

All 5 Releases


More Releases for Implantable

Nanotechnology in Medical Devices Market 2028 by Implantable Materials, Active I …
The Insight Partners analysts forecasts the latest report on “Global Nanotechnology in Medical Devices Market (Covid-19) Impact and Analysis by 2028”, according to report; The Nanotechnology in Medical Devices Market report covers the overall and all-inclusive analysis of Market with all its factors that have an impact on market growth. This report is anchored on the thorough qualitative and quantitative assessment of the Nanotechnology in Medical Devices Market. The study
Nanomedical Devices Market Highest CAGR of 10.29% by 2023 | By Types Implantable …
The Global Nano Medical Devices Market is expected to grow at a CAGR of 10.29% during Forecasted Period 2017-2023. Nanomedical Devices Market - Segmentation The global Nanomedical Devices Market has been segmented on the basis of applications, end users, types, and lastly region. As per application-based segmentation, this market has been segmented into disease treatment & diagnosis, drug release regulation and other. Disease treatment & diagnosis has been sub-segmented into cancer, cardiovascular
Nanomedical Devices Market Highest CAGR of 10.29% by 2023 | By Types Implantable …
Nanomedical Devices Market - Segmentation The global nanomedical devices market has been segmented on the basis of applications, end users, types, and lastly region. As per application-based segmentation, this market has been segmented into disease treatment & diagnosis, drug release regulation and other. Disease treatment & diagnosis has been sub-segmented into cancer, cardiovascular diseases neurological diseases, and other. With regards to end users, the market has been segmented into clinics, hospitals,
Active Implantable Medical Devices Market (Implantable Cardioverter Defibrillato …
Global Active Implantable Medical Devices Market 2018 report includes Active Implantable Medical Devices Market Size, Revenue, market Share, Active Implantable Medical Devices industry volume, market Trends, Active Implantable Medical Devices Growth aspects. A wide range of applications, Utilization ratio, Supply and demand analysis are also consist in the report. It shows manufacturing capacity, Active Implantable Medical Devices Price during the Forecast period from 2018 to 2025. For In depth Information Get
Active Implantable Medical Devices Market by Product Type (Pacemaker, Implantabl …
The Global Active Implantable Medical Devices Market by product type (pacemaker, implantable cardioverter defibrillator, cardiac resynchronization therapy devices, neurostimulator, drug infusion pump, implantable loop recorder, cochlear implant, and others), and region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 16,721.2 million in 2016 and is projected to exhibit a CAGR of 5.4% over the forecast period (2017–2025), as highlighted in a new
Implantable Cardioverter Defibrillators Contribute Largest Revenue to the Global …
According to the study, the global active implantable medical devices market is likely to grow from $17.0 billion in 2016 to $28.9 billion by 2023. Technological advancements, increasing prevalence of cardiovascular diseases, rising healthcare expenditures and increasing research and development activities have been driving the growth of the global active implantable medical devices market. The market is further expected to gain revenue due to increasing geriatric population and incidence of